Skip to main content
. 2023 Apr 15;39(3):455–475. doi: 10.1007/s43188-023-00177-1

Table 3.

Haematological findings in male Swiss Albino mice treated with ruthenium biochanin-A complex for 28 days repeated-dose oral sub-acute toxicity study

Parameters Control ruthenium biochanin-A (50 mg/kg) Ruthenium biochanin-A (100 mg/kg) Ruthenium biochanin-A (200 mg/kg) Ruthenium biochanin-A (400 mg/kg)
Haemoglobin (Gm%) 12.4 ± 0.008 12.40 ± 0.008 12.38 ± 0.009 12.36 ± 0.005*# 12.41 ± 0.006α
Total RBC count (×106/µL) 4.31 ± 0.001 4.31 ± 0.001 4.32 ± 0.002 4.31 ± 0.003 4.30 ± 0.001
WBC count (×103/µL) 5.43 ± 0.001 5.49 ± 0.004* 5.52 ± 0.002* 5.76 ± 0.003*#$ 15.12 ± 0.001*#$α
Platelet count (×105/µL) 6.92 ± 0.005 6.91 ± 0.002 7.07 ± 0.003*# 7.11 ± 0.002*#$ 6.87 ± 0.003*$α
MCV (fL) 90.86 ± 0.004 88.92 ± 0.008*# 91.88 ± 0.005*# 90.88 ± 0.006#$ 90.95 ± 0.009*#$α
MCH (pg) 28.87 ± 0.003 28.75 ± 0.005*# 27.85 ± 0.005* 28.77 ± 0.006*$ 28.88 ± 0.004#$α
MCHC (%) 2.13 ± 0.004 31.12 ± 0.005* 32.13 ± 0.006*# 32.13 ± 0.006*# 33.14 ± 0.004*#$α
Neutrophil (%) 55.03 ± 0.006 45.34 ± 0.006* 46.73 ± 0.006*# 55.07 ± 0.008*#$ 48.14 ± 0.007*#$α
Eosinophil (%) 2.45 ± 0.01 2.55 ± 0.005* 3.02 ± 0.005*# 3.46 ± 0.006*#$ 2.58 ± 0.006*#$α
Basophil (%) 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00
Lymphocyte (%) 45.05 ± 0.12 37.05 ± 0.01* 20.64 ± 0.07*# 40.17 ± 0.007*#$ 42.76 ± 0.009*#$α
Monocyte (%) 3.18 ± 0.003 3.18 ± 0.005 4.03 ± 0.013*# 3.88 ± 0.006*#$ 3.56 ± 0.006*#$α

The values were depicted as mean ± SEM (n = 6). The values were analyzed through one-way ANOVA associated with Tukey’s multiple comparison test

MCV mean corpuscular volume, MCH mean corpuscular haemoglobin, MCHC mean corpuscular haemoglobin concentration, RBC red blood cell, WBC white blood cell

*Significant difference as compared to the control group (p < 0.05)

#Significant difference as compared to the 50 mg/kg complex treated group (p < 0.05)

$Significant difference as compared to the 100 mg/kg complex treated group (p < 0.05)

αSignificant difference as compared to the 200 mg/kg complex treated group (p < 0.05)